Modification of proteins and lipids by myeloperoxidase.

[1]  J. Crowley,et al.  p-Hydroxyphenylacetaldehyde, the Major Product of l-Tyrosine Oxidation by the Myeloperoxidase-H2O2-Chloride System of Phagocytes, Covalently Modifies ε-Amino Groups of Protein Lysine Residues* , 1997, The Journal of Biological Chemistry.

[2]  S. L. Hazen,et al.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. , 1997, The Journal of clinical investigation.

[3]  S. L. Hazen,et al.  Reactive Nitrogen Intermediates Promote Low Density Lipoprotein Oxidation in Human Atherosclerotic Intima* , 1997, The Journal of Biological Chemistry.

[4]  S. L. Hazen,et al.  Molecular Chlorine Generated by the Myeloperoxidase-Hydrogen Peroxide-Chloride System of Phagocytes Converts Low Density Lipoprotein Cholesterol into a Family of Chlorinated Sterols* , 1996, The Journal of Biological Chemistry.

[5]  S. L. Hazen,et al.  Human neutrophils employ chlorine gas as an oxidant during phagocytosis. , 1996, The Journal of clinical investigation.

[6]  R. Stocker,et al.  Presence of hypochlorite-modified proteins in human atherosclerotic lesions. , 1996, The Journal of clinical investigation.

[7]  S. Hazen,et al.  p-Hydroxyphenylacetaldehyde Is the Major Product of L-Tyrosine Oxidation by Activated Human Phagocytes , 1996, The Journal of Biological Chemistry.

[8]  A. Kettle.  Neutrophils convert tyrosyl residues in albumin to chlorotyrosine , 1996, FEBS letters.

[9]  T. Charlton,et al.  Chlorination of Tyrosyl Residues in Peptides by Myeloperoxidase and Human Neutrophils (*) , 1995, The Journal of Biological Chemistry.

[10]  Wei Li,et al.  Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. , 1994, Biochemistry.

[11]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[12]  A. Sevanian,et al.  Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. , 1992, Atherosclerosis.

[13]  E. Roitman,et al.  Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. , 1992, Archives of biochemistry and biophysics.

[14]  U. Steinbrecher,et al.  Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[16]  H. Rosen,et al.  Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. , 1990, Biochemistry.

[17]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[18]  B. Sobel,et al.  Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. , 1988, Arteriosclerosis.

[19]  S. Weiss,et al.  Brominating oxidants generated by human eosinophils. , 1986, Science.

[20]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[21]  H. Iwamoto,et al.  Crystallization and properties of myeloperoxidase from normal human leukocytes. , 1986, Journal of biochemistry.

[22]  R. Clark,et al.  Oxidant membrane injury by the neutrophil myeloperoxidase system. II. Injury by stimulated neutrophils and protection by lipid-soluble antioxidants. , 1985, Journal of immunology.

[23]  R. Clark,et al.  Oxidant membrane injury by the neutrophil myeloperoxidase system. I. Characterization of a liposome model and injury by myeloperoxidase, hydrogen peroxide, and halides. , 1985, Journal of immunology.

[24]  R. Lehrer,et al.  Assessment of chlorination by human neutrophils , 1983, Nature.

[25]  S. Klebanoff.  Oxygen metabolism and the toxic properties of phagocytes. , 1980, Annals of internal medicine.

[26]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[27]  J. Schultz,et al.  Studies on the chlorinating activity of myeloperoxidase. , 1976, The Journal of biological chemistry.

[28]  Dennis P. Nelson,et al.  Enthalpy of Decomposition of Hydrogen Peroxide by Catalase at 25C (with Molar Extinction Coefficients of H2O2 Solutions in the UV) , 1972 .

[29]  J. Morris,et al.  The Acid Ionization Constant of HOCl from 5 to 35 , 1966 .

[30]  S. L. Hazen,et al.  Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. , 1997, Free radical biology & medicine.

[31]  J. Berliner,et al.  The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.

[32]  A. Kettle,et al.  Assays for the chlorination activity of myeloperoxidase. , 1994, Methods in enzymology.

[33]  U. Steinbrecher,et al.  Role of oxidatively modified LDL in atherosclerosis. , 1990, Free radical biology & medicine.

[34]  J. McCloskey.  Electron ionization mass spectra of trimethylsilyl derivatives of nucleosides. , 1990, Methods in enzymology.

[35]  V. Schumaker,et al.  [6] Sequential flotation ultracentrifugation , 1986 .